Association Between Prosthetic Knee Effusions and Phosphodiesterase Type-5 Enzyme Inhibitor Use After Total Knee Arthroplasty: A Case Report.

Jakob J Anibas Nicholas W BradyNaga Suresh Cheppalli

Published in: JBJS case connector (2023)

This report describes a previously unknown adverse effect of PDE5 inhibitor use in a prosthetic joint after TKA. We hope to encourage physicians managing patients after joint replacement to be aware of the association between PDE5 inhibitor use and recurrent joint effusions to improve postoperative outcomes.

Keyphrases

end stage renal disease
total knee arthroplasty
chronic kidney disease
ejection fraction
newly diagnosed
primary care
patients undergoing
peritoneal dialysis
prognostic factors
knee osteoarthritis
metabolic syndrome
weight loss
patient reported
anterior cruciate ligament